Being diagnosed with prostate cancer does not always mean you need treatment immediately. That can feel confusing at first. You may hear the word “cancer” and feel that something must be done straight away. But prostate cancer can behave very differently from one man to another.
Some prostate cancers grow slowly and may not cause problems for many years. Others are more likely to grow, spread, or need active treatment. This is why your specialist may talk to you about different options, including prostate cancer surgery and active surveillance.
Prostate cancer surgery usually means radical prostatectomy, where the whole prostate gland is removed. Active surveillance means carefully monitoring the cancer and only starting treatment if there are signs that it is changing or becoming more concerning.
Neither option is automatically right for everyone. The best choice depends on your cancer risk, PSA level, biopsy results, MRI findings, age, general health, personal priorities, and how you feel about treatment side effects.
What Is Prostate Cancer Surgery?
Prostate cancer surgery is an operation used to remove the prostate gland, and it is most commonly called a radical prostatectomy. During the procedure, your whole prostate is removed along with the seminal vesicles, which help produce fluid for semen. In some cases, nearby lymph nodes may also be removed if there is concern that the cancer could have spread beyond the prostate.
The surgery can be performed using robotic, laparoscopic, or open techniques. Robotic surgery is now widely used in many hospitals and specialist centres because it allows your surgeon to operate through small cuts using very precise instruments and a highly magnified view. For many patients, this can support a smoother recovery and may help improve surgical precision.
The main goal of surgery is to remove the cancer and lower the risk of it returning in the future. Surgery may be suitable for you if you have localised prostate cancer, and in some cases it may also be considered for selected men with locally advanced disease. The decision usually depends on factors such as your scan results, cancer characteristics, general health, and overall treatment goals.
What Is Active Surveillance?
Active surveillance is a structured monitoring plan for your prostate cancer. It is usually considered when the cancer appears low risk or unlikely to cause harm in the near future.
Instead of treating the cancer straight away, your specialist monitors it closely with regular tests. These may include PSA blood tests, MRI scans, prostate examinations, and repeat biopsies when needed. The aim is to avoid or delay treatment side effects while still keeping a careful watch on the cancer.
If your cancer shows signs of growing or becoming more aggressive, treatment such as surgery or radiotherapy may then be recommended. Active surveillance does not mean your cancer is being ignored. It means your condition is being monitored carefully, with treatment available if it becomes necessary for you.
Why Some Men Do Not Need Immediate Treatment
Not all prostate cancers behave aggressively. Some prostate cancers grow very slowly over many years and may never cause symptoms or shorten your life, particularly if they are detected early and appear low risk on scans, PSA testing, and biopsy results. In some men, the cancer may remain stable for such a long time that immediate treatment is not necessary.
Treating these cancers straight away may expose you to side effects such as urinary leakage, erectile dysfunction, or bowel problems without giving you a clear benefit. This is why active surveillance can be a sensible option for selected men, allowing you to maintain your quality of life while your cancer is monitored carefully.
The key point is careful selection. Active surveillance is usually most appropriate when your cancer appears low risk, small in volume, and confined to the prostate. If the cancer looks more aggressive or shows signs of spread, your specialist may recommend active treatment more strongly.
Why Some Men Choose Surgery
Some men choose surgery because they want the prostate removed completely. For you, this may feel psychologically reassuring, particularly if the idea of living with untreated cancer causes ongoing anxiety or uncertainty.
Surgery also provides a full pathology report because your entire prostate is examined after removal. This can show whether the cancer was fully contained, whether the surgical margins are clear, and whether any removed lymph nodes contain cancer. Many men find this extra information helpful when understanding their diagnosis more clearly.
Surgery may also be recommended if your cancer appears more likely to grow or spread, or if active surveillance is not considered safe enough in your situation. However, surgery is still major treatment and can lead to side effects such as urinary leakage and erectile dysfunction, so the decision should always be considered carefully with your specialist team.
The Main Difference Between the Two Options
The main difference is timing. Surgery treats the cancer immediately by removing the prostate. Active surveillance delays treatment unless there are signs that the cancer is progressing. With surgery, you may reduce the risk of progression sooner, but you accept the immediate risks and side effects of treatment.
With active surveillance, you may avoid or delay side effects, but you accept the need for regular monitoring and the possibility that treatment may be needed later. Both approaches can be appropriate in the right setting. The best choice depends on the cancer and on what matters most to you.
| Factor | Prostate Cancer Surgery | Active Surveillance |
| Main Goal | Remove the prostate and cancer immediately | Monitor cancer closely and delay treatment unless needed |
| Treatment Type | Major operation (radical prostatectomy) | Structured monitoring plan |
| Timing | Immediate treatment | Delayed treatment unless cancer changes |
| Suitable For | Intermediate or higher-risk localised cancer | Low-risk localised prostate cancer |
| Hospital Stay | Usually 1–2 nights after robotic surgery | No hospital stay required |
| Recovery Time | Several weeks to months | No surgical recovery |
| Urinary Leakage Risk | Common after surgery | Usually not caused by surveillance |
| Erectile Dysfunction Risk | Possible after surgery | Usually unaffected initially |
| Fertility Impact | Natural fertility usually lost | Fertility usually preserved |
| PSA Monitoring | Required after surgery | Regular ongoing monitoring required |
| Emotional Impact | Relief for some men after treatment | Anxiety possible due to untreated cancer |
| Future Treatment | Additional treatment sometimes needed | Surgery or radiotherapy may still be needed later |
Which Cancers Are More Suitable for Active Surveillance?
Active surveillance is often considered for low-risk localised prostate cancer. This may include cancers with a low PSA, low-grade biopsy results, limited cancer found on biopsy, and reassuring MRI findings.
Your specialist will look at the whole picture rather than one test alone. They may consider your PSA level, PSA density, Gleason score or Grade Group, MRI findings, number of biopsy cores involved, cancer volume, age, health, and preferences.
If the cancer appears very unlikely to cause harm in the near future, active surveillance may help you avoid unnecessary treatment. However, if the cancer shows higher-risk features, active surveillance may not be recommended.
Which Cancers Are More Suitable for Surgery?
Surgery may be more suitable when the cancer is localised but has features that suggest treatment is needed. This may include intermediate-risk or higher-risk prostate cancer, depending on the details.
Surgery may also be considered if the cancer appears contained and the patient is fit enough for a major operation. Your specialist may recommend surgery if they believe removing the prostate offers a strong chance of long-term cancer control.
Surgery may also be chosen if active surveillance would feel too stressful for you or if you prefer active treatment after understanding the risks. However, surgery is not usually the best choice if the cancer is very low risk and safe monitoring is a better option.
PSA Level and Treatment Choice
PSA is an important part of the decision. PSA stands for prostate-specific antigen. It is a protein made by prostate cells and can be raised in prostate cancer, but also in benign prostate enlargement, infection, or inflammation.
When prostate cancer has already been diagnosed, PSA helps your specialist understand the cancer’s risk level. A low PSA with favourable biopsy and MRI results may support active surveillance.
A higher PSA may suggest a need for treatment, especially if it is combined with higher-grade cancer or concerning MRI findings. PSA is never used alone. It is interpreted alongside biopsy results, MRI findings, prostate size, symptoms, and overall risk.
Biopsy Results Matter
Your biopsy results are one of the most important factors when deciding between surgery and active surveillance. The biopsy helps show how abnormal the cancer cells look, and you may hear terms such as Gleason score or Grade Group during these discussions.
Lower-grade cancers are often considered more suitable for active surveillance because they are less likely to grow or spread quickly. Higher-grade cancers are usually treated more actively because they may behave more aggressively over time.
The biopsy also shows how much cancer was found and where it is located within your prostate. If only a small amount of low-grade cancer is present, careful monitoring may be reasonable for you. If a larger amount of cancer is found or the grade is higher, your specialist may recommend surgery or another active treatment more strongly.
MRI Findings Matter Too
MRI helps your specialist see where your prostate cancer is located and whether it appears contained within the prostate gland. A reassuring MRI result may support active surveillance in selected men with low-risk disease.
If the MRI shows a larger tumour, possible spread outside the prostate, or cancer close to important structures, active treatment such as surgery or radiotherapy may be considered more appropriate for you. MRI also helps guide biopsy decisions and overall treatment planning.
For surgery, MRI can help your surgeon understand the exact tumour location and whether nerve-sparing surgery may be possible. This is important because it may affect recovery of urinary control and erectile function after treatment. MRI therefore does not only help diagnose prostate cancer, but also helps determine which treatment approach makes the most sense for your situation.
Age and General Health
Your age and general health are important factors when deciding between active surveillance and surgery. A younger, fit man with a cancer that may progress over time is often more likely to benefit from active treatment.
An older man with low-risk prostate cancer and other significant health conditions may be more likely to benefit from monitoring instead of immediate treatment. This is because some prostate cancers grow slowly, and in certain situations the risks and side effects of treatment may outweigh the potential benefits.
However, age alone does not decide treatment. A fit older man may still be suitable for surgery, while a younger man with very low-risk cancer may still choose active surveillance. The decision should always be personalised to your cancer features, overall health, and personal preferences.
Life Expectancy and Long-Term Benefit
Treatment should offer meaningful benefit. If prostate cancer is low risk and slow-growing, immediate surgery may not always improve life expectancy, but it may cause side effects.
If the cancer is more likely to grow or spread, active treatment may offer clearer long-term benefit. Your specialist may discuss life expectancy, overall health, cancer risk, and treatment goals.
This can feel like a difficult conversation, but it is important. The aim is not just to treat cancer because it exists. The aim is to choose treatment that is likely to help you live longer, live better, or both.
Benefits of Active Surveillance
One of the biggest benefits of active surveillance is that it may help you avoid or delay treatment side effects. If your prostate cancer is low risk, you may be able to continue normal life without having immediate surgery or radiotherapy.
Treatments such as surgery and radiotherapy can affect urinary control, erections, ejaculation, fertility, bowel function, and emotional wellbeing. By monitoring the cancer carefully instead of treating it straight away, you may avoid these effects for many years or possibly altogether.
You still remain under close medical follow-up, with regular PSA tests, scans, and other assessments when needed. This means treatment can still begin if the cancer shows signs of changing. For many men, this balance feels reassuring because it avoids overtreatment while still keeping a safety net in place.
Concerns With Active Surveillance
Active surveillance can also have emotional challenges. Some men feel anxious knowing that cancer is still in the body. You may worry before each PSA test or scan. You may wonder whether you are taking a risk by waiting.
You may also need repeat biopsies, which can cause discomfort, bleeding, infection risk, or anxiety. Active surveillance requires commitment. You need to attend appointments, have regular tests, and follow your specialist’s plan. If you are unlikely to attend follow-up, active surveillance may not be the safest option.
Benefits of Surgery
Surgery removes the prostate gland and the cancer within it. For suitable patients, this can offer strong cancer control and may be curative. Surgery also gives detailed pathology information because the whole prostate is examined after removal. This can help your specialist understand whether the cancer was fully contained, whether margins are clear, and whether further treatment may be needed.
Some men feel more comfortable psychologically after the prostate has been removed. Surgery may also reduce the need for long-term uncertainty around monitoring in men whose cancer clearly needs treatment.
Risks of Surgery
Surgery carries risks and possible side effects. These can include urinary leakage, erectile dysfunction, dry orgasm, loss of natural fertility, catheter discomfort, pain, bleeding, infection, blood clots, and wound problems.
Recovery takes time. You will usually have a catheter after surgery, and urinary control may take weeks or months to improve. Erectile recovery can take longer and depends on age, erections before surgery, nerve-sparing, cancer location, and general health. Surgery can be the right choice for many men, but it should not be chosen without understanding these risks.
Urinary Control Comparison
Active surveillance does not usually cause urinary leakage because no treatment is being given immediately. Surgery can cause urinary leakage, especially after catheter removal. Some men recover control quickly, while others take longer. A smaller number may have longer-term leakage and need ongoing support.
This does not mean surgery should be avoided if it is needed for cancer control. It means urinary side effects should be part of the decision. If urinary control is one of your biggest concerns, ask your specialist what your personal risk may be and what support is available.
Sexual Function Comparison
Active surveillance does not directly cause erectile dysfunction because you are not having immediate treatment to the prostate. This is one reason some men prefer monitoring when their cancer appears low risk and suitable for surveillance.
Surgery can affect erections because the nerves involved in erectile function run very close to the prostate gland. Nerve-sparing surgery may reduce this risk in suitable patients, but it is not always possible depending on the location and extent of your cancer. Even when nerve-sparing surgery is performed, recovery of erections can still take time.
Some men need tablets, vacuum devices, injections, or other treatments after surgery to help with erectile function. If sexual function is important to you, it is important to discuss this before making a treatment decision. Your specialist should explain realistic expectations based on your age, current erections, cancer position, and planned surgical approach.
Fertility Comparison
Active surveillance does not usually affect your fertility because the prostate and seminal vesicles are not removed. This means you continue to produce semen naturally while your cancer is being monitored.
Surgery affects natural fertility because the prostate and seminal vesicles are removed during the operation. After surgery, you will no longer ejaculate semen. You may still be able to have an orgasm, but it will usually be dry.
If you may want children in the future, sperm storage should be discussed before surgery takes place. This can sometimes be overlooked when you are focused on cancer treatment decisions, but it is an important conversation to have early. Fertility discussions are best done before treatment begins, not afterwards.
Emotional Comparison
Both options can affect you emotionally, but in different ways. With active surveillance, you may feel anxious because the cancer is being monitored rather than treated immediately.
With surgery, you may feel relief that the prostate has been removed, but you may also feel stressed about recovery, leakage, erections, PSA follow-up, and body changes. Neither option is emotionally easy for everyone.
Your personality, support system, cancer risk, and attitude towards uncertainty all matter. Some men tolerate monitoring well. Others find it very difficult. Some men accept surgery side effects because they feel more comfortable treating the cancer directly.
Follow-Up After Active Surveillance
Active surveillance involves regular follow-up to monitor your prostate cancer carefully over time. This may include PSA blood tests, MRI scans, prostate examinations, and repeat biopsies when needed.
Your follow-up schedule may vary depending on your risk level, previous results, and the hospital pathway you are on. If your PSA rises, MRI findings change, or a biopsy shows higher-grade cancer, your specialist may recommend moving towards treatment such as surgery or radiotherapy.
Before choosing active surveillance, it is important that you understand the monitoring plan clearly. Ask how often tests will happen, what changes would trigger treatment, and what happens if you miss appointments. Clear follow-up makes active surveillance both safer and less stressful for you.
Follow-Up After Surgery
After surgery, your follow-up care focuses mainly on PSA testing and recovery from treatment. Because your prostate has been removed, PSA levels should usually fall to a very low or undetectable level after the operation.
Your specialist will continue monitoring your PSA over time. If PSA remains very low, this is generally reassuring. If it rises later, further assessment or additional treatment may sometimes be needed.
Follow-up appointments also give you the chance to discuss urinary leakage, erectile dysfunction, emotional wellbeing, and your return to normal activities. Surgery does not end the prostate cancer journey immediately. Instead, it begins a new phase of recovery, adjustment, and ongoing monitoring for you.
What If Cancer Progresses During Active Surveillance?
If your prostate cancer progresses during active surveillance, treatment can still be started when needed. This may involve surgery, radiotherapy, or another treatment approach depending on the type of change that has been detected.
Progression may be identified through rising PSA levels, changes seen on MRI scans, or biopsy results showing higher-grade cancer. The aim of active surveillance is not to avoid treatment forever, but to begin treatment if the cancer starts behaving in a way that suggests it may become more harmful.
This is why monitoring must be regular and carefully structured. Active surveillance is safest when both you and your medical team follow the follow-up plan closely and respond promptly to any important changes.
What If PSA Rises After Surgery?
If your PSA rises after surgery, your specialist will look carefully at the pattern over time. They may repeat the test and assess how quickly the PSA is increasing rather than relying on a single result alone.
Your team will also review your final pathology report, including the cancer stage, Grade Group, surgical margins, and whether any lymph nodes contained cancer. This information helps estimate the likelihood of recurrence and guide the next steps for you.
Further treatment may include radiotherapy, hormone therapy, or closer monitoring depending on your individual situation. A rising PSA does not mean there are no treatment options available. It means your specialist team needs to decide the most appropriate next step based on your overall risk and recovery.
When Surgery May Be the Better Option
Surgery may be the better option if your prostate cancer appears more likely to grow or spread over time. It is often recommended for some intermediate-risk cancers and selected higher-risk cancers where active treatment may offer a clearer long-term benefit.
It may also be suitable if you are fit for surgery, have a longer life expectancy, and prefer a more active treatment approach rather than ongoing monitoring. In some situations, the cancer features may make active surveillance less safe or less appropriate for you.
Surgery can also feel psychologically reassuring for some men, particularly if living with untreated cancer would cause significant anxiety. However, the decision should still involve a careful discussion about possible side effects, recovery, and alternative treatment options before you make a final choice.
When Active Surveillance May Be the Better Option
Active surveillance may be the better option if your prostate cancer appears low risk and unlikely to cause harm in the near future. It can also be suitable if you want to avoid or delay treatment side effects for as long as it is safe to do so.
This approach is often considered when your PSA results, biopsy findings, MRI scans, and clinical assessment suggest the cancer is small, low grade, and contained within the prostate. Active surveillance may also be preferred if surgery or radiotherapy would carry higher risks because of your age, other health conditions, or overall fitness.
The most important point is that active surveillance must be safe and structured. You still need regular monitoring with PSA tests, scans, and sometimes repeat biopsies. It is not the same as ignoring the cancer, but rather carefully watching it with treatment available if changes occur.
Why Treatment Decisions Should Not Be Rushed
A prostate cancer diagnosis can make you feel pressured to act quickly. But in many localised cases, you usually have time to understand your options. This does not mean delaying care unnecessarily.
It means taking enough time to compare surgery, active surveillance, radiotherapy, side effects, and long-term outcomes. Rushed decisions can lead to regret. You should feel that you understand why a treatment is being recommended and what may happen if you choose a different path. If you are unsure, asking for a second opinion can be helpful.
How to Think About Risk
Choosing between surgery and active surveillance often means balancing different risks. With active surveillance, the main concern is whether the cancer could grow or become more serious before treatment is needed. With surgery, the main concern is treatment side effects and recovery.
Your specialist can help you understand which risk is larger in your case. This depends on cancer grade, PSA, MRI, biopsy volume, age, health, and personal values. There is no universal answer. The right choice is the one that fits your medical situation and feels acceptable to you.
The Role of Your Personal Priorities
Your personal priorities play a very important role when deciding between active surveillance and surgery. Some men feel more comfortable avoiding treatment side effects for as long as possible, while others prefer to treat the cancer immediately even if that means accepting surgical risks.
You may be most concerned about urinary control, sexual function, work, travel, anxiety, or long-term cancer control. Another person with the same diagnosis may prioritise completely different things. That is why prostate cancer treatment decisions are rarely one-size-fits-all.
There is no wrong priority. The important thing is to speak honestly with your specialist about what matters most to you and how you feel about the different options. Good treatment decisions are based not only on medical facts, but also on your personal values, lifestyle, and goals.
Can You Change Your Mind?
In many cases, yes. If you start active surveillance and the cancer changes, you may move to surgery or radiotherapy. If you are considering surgery but feel unsure, you can usually ask for more time, more explanation, or a second opinion, as long as your specialist agrees it is safe.
The decision should not feel forced. However, if your cancer has higher-risk features, your team may advise that treatment should not be delayed too long. Ask how much time you realistically have to decide. Knowing this can reduce pressure and help you think clearly.
Speak to Our Specialist
If you are deciding between surgery and active surveillance, a specialist consultation can help you understand your options more clearly. Treatment decisions are often influenced by several factors, including your PSA level, MRI findings, biopsy results, cancer grade, cancer stage, age, general health, urinary symptoms, sexual function, and personal priorities.
If you are looking for a prostate cancer clinic to discuss surgery, active surveillance, and other treatment options, you can arrange a consultation to explore which approach may be most appropriate for your diagnosis and lifestyle.
The right decision should be based on both your cancer risk and your personal goals, not fear or pressure. A good specialist discussion should help you feel informed, supported, and confident about the path you choose.
FAQs
1. Is active surveillance safe for prostate cancer?
Yes, active surveillance can be safe for selected men with low-risk, localised prostate cancer. It involves regular PSA tests, MRI scans, and sometimes repeat biopsies to monitor the cancer closely and start treatment if changes occur.
2. How do doctors decide between surgery and active surveillance?
The decision depends on several factors, including PSA level, biopsy results, MRI findings, cancer grade, age, general health, and personal priorities. Your specialist looks at the overall risk rather than relying on one test alone.
3. What are the main benefits of active surveillance?
The biggest benefit is avoiding or delaying treatment side effects such as urinary leakage, erectile dysfunction, and bowel problems while still keeping the cancer under close observation.
4. What are the main risks or side effects of prostate cancer surgery?
Surgery can lead to urinary leakage, erectile dysfunction, dry orgasm, fertility loss, catheter discomfort, bleeding, infection, and recovery challenges.
5. Can prostate cancer progress during active surveillance?
Yes, some cancers may progress over time. This is why active surveillance includes regular monitoring so treatment such as surgery or radiotherapy can begin if the cancer becomes more aggressive.
6. Does active surveillance mean the cancer is being ignored?
No. Active surveillance is a structured medical plan involving ongoing monitoring with PSA tests, MRI scans, examinations, and biopsies when needed.
7. Will prostate cancer surgery affect sexual function?
It can. Surgery may affect erections because the nerves responsible for erectile function run close to the prostate. Recovery varies depending on age, baseline erectile function, cancer location, and whether nerve-sparing surgery is possible.
8. Which prostate cancers are usually suitable for active surveillance?
Active surveillance is most commonly considered for low-risk prostate cancer with favourable PSA levels, low-grade biopsy findings, limited cancer volume, and reassuring MRI results.
9. What happens if PSA rises after prostate cancer surgery?
Your specialist will usually repeat the PSA test, review the pathology report, and assess the pattern of PSA rise over time. Additional treatment such as radiotherapy or hormone therapy may sometimes be recommended.
10. Can I change my mind after choosing active surveillance?
In many cases, yes. If the cancer changes or you decide monitoring no longer feels right for you, treatment such as surgery or radiotherapy can still be considered later.
Final Thoughts: Choosing the Right Path for Your Prostate Cancer Care
Choosing between prostate cancer surgery and active surveillance is a very personal decision. The right option depends not only on your PSA level, MRI findings, biopsy results, and cancer grade, but also on how you feel about monitoring, treatment side effects, recovery, and long-term cancer control. Some men feel more comfortable treating the cancer immediately, while others prefer careful monitoring to avoid or delay unnecessary treatment.
There is no single approach that suits everyone. What matters most is understanding your diagnosis clearly, knowing the potential benefits and risks of each option, and making a decision that fits both your medical situation and your personal priorities. Taking time to ask questions, seek specialist advice, and fully understand your choices can help you feel more confident about the path ahead. . If you are looking for a prostate cancer clinic in London, contact us to arrange a consultation. We can provide personalised advice about your diagnosis, explain your treatment options, and support you throughout your recovery.
References:
- Hamdy, F.C., Donovan, J.L., Lane, J.A., Mason, M., Metcalfe, C., Holding, P., Davis, M., Peters, T.J., Turner, E.L., Martin, R.M. and Oxley, J., 2016. 10-year outcomes after monitoring, surgery, or radiotherapy for localised prostate cancer. New England Journal of Medicine, 375(15), pp.1415–1424. Available at: https://pubmed.ncbi.nlm.nih.gov/27626136/
- Wilt, T.J., Jones, K.M., Barry, M.J., Andriole, G.L., Culkin, D., Wheeler, T., Aronson, W.J., Brawer, M.K. and Crawford, E.D., 2012. Radical prostatectomy versus observation for localized prostate cancer. New England Journal of Medicine, 367(3), pp.203–213. Available at: https://pubmed.ncbi.nlm.nih.gov/22808955/
- Loeb, S., Bruinsma, S.M., Nicholson, J. and Carroll, P.R., 2020. Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification. Cancers, 12(11), p.3117. Available at: https://www.mdpi.com/2072-6694/13/17/4251
- Giganti, F., Stabile, A., Stavrinides, V. and Moore, C.M., 2023. Active surveillance for prostate cancer: past, current, and future trends. Journal of Personalized Medicine, 13(4), p.629. Available at: https://www.mdpi.com/2075-4426/13/4/629
- van den Bergh, R.C.N., Steyerberg, E.W., Khatami, A., Aus, G., Bangma, C.H., Carlsson, S., Hugosson, J. and Roobol, M.J., 2012. Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. European Urology, 62(2), pp.195–200. Available at: https://www.sciencedirect.com/science/article/abs/pii/S0302283812001868